CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash Flows From Operating Activities:
Net earnings/(loss)	$ 2,462	$ (11,908)
Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:
Depreciation and amortization, net	1,012	2,532
Deferred income taxes	223	(711)
Stock-based compensation	144	133
Divestiture gains and royalties	(292)	(280)
Acquired IPRD	188	12,949
Equity investment (gains)/losses, net	78	(102)
Other adjustments	10	23
Changes in operating assets and liabilities:
Receivables	15	479
Inventories	(169)	(218)
Accounts payable	(85)	300
Rebates and discounts	(627)	(665)
Income taxes payable	54	910
Other	(1,059)	(608)
Net cash provided by operating activities	1,954	2,834
Cash Flows From Investing Activities:
Sale and maturities of marketable debt securities	220	747
Purchase of marketable debt securities	(636)	(274)
Proceeds from sales of equity investments	12	5
Capital expenditures	(260)	(284)
Divestiture and other proceeds	243	241
Acquisition and other payments, net of cash acquired	(78)	(20,053)
Net cash used in investing activities	(499)	(19,618)
Cash Flows From Financing Activities:
Proceeds from issuance of short-term debt obligations	0	2,987
Other short-term financing obligations, net	368	83
Proceeds from issuance of long-term debt	0	12,883
Dividends	(1,258)	(1,212)
Stock option proceeds and other, net	(103)	(97)
Net cash (used in)/provided by financing activities	(993)	14,644
Effect of exchange rates on cash, cash equivalents and restricted cash	66	(45)
Increase/(decrease) in cash, cash equivalents and restricted cash	528	(2,185)
Cash, cash equivalents and restricted cash at beginning of period	10,347	11,519
Cash, cash equivalents and restricted cash at end of period	$ 10,875	$ 9,334